Please login to the form below

Not currently logged in
Email:
Password:

esketamine

This page shows the latest esketamine news and features for those working in and with pharma, biotech and healthcare.

J&J files would-be prostate cancer blockbuster in US

J&J files would-be prostate cancer blockbuster in US

for multiple myeloma, and antidepressant esketamine - will help drive strong earnings.

Latest news

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech,...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics